Lv1
68 积分 2024-11-14 加入
HER2 testing: evolution and update for a companion diagnostic assay
3天前
已完结
HER2 immunoreactivity in advanced non-p53abn endometrial carcinoma: Association with clinical features, prognosis, and molecular characteristics
3天前
求助中
HER2 expression in an endometrial cancer cohort
4天前
已完结
Comparison of HER2 Scoring Systems in Endometrial Cancer
4天前
求助中
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours
11天前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
17天前
已完结
Rationale for Investigation of Neoadjuvant Chemoimmunotherapy Before Chemoradiation in Unresectable Stage III Non–Small Cell Lung Cancer
17天前
已完结
Progress in immunotherapy for resectable head and neck squamous cell carcinoma
25天前
已完结
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
25天前
已完结
Validation of the Generic Version of China Health Related Outcomes Measures (CHROME‐G) among individuals with type 2 diabetes in China
25天前
已完结
皖公网安备34019202002308
